Search
for
Sort by
Research 61–90 of 1000+
- Tebentafusp-tebn (Kimmtra®)
- Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- The relationship between keratin 18 and epithelial-derived tumors: as a diagnostic marker, prognostic marker, and its role in tumorigenesis
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Lysocellin, a metabolite of the novel drug ‘alopestatin’, induces G1 arrest and prevents cytotoxicity induced by etoposide
- An Overview of Harmful Effects of Polycystic Ovary Syndrome
- Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Severe Refractory Scarring Alopecia Associated With Combinational Use of Ficlatuzumab (AV-299) and Gefitinib
- Cutaneous toxicities of new treatments for melanoma
- Rash from EGFR inhibitors: Opportunities and challenges for palliation
- Off-label prescriptions: patient safety first
- Mechanism of Targeting the Hedgehog Signaling Pathway against Chemotherapeutic Resistance in Multiple Myeloma
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- HOTTIP Mediated Therapy Resistance in Glioma Cells Involves Regulation of EMT-Related miR-10b
- New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
- Trichomegaly of the eyelashes following treatment with cetuximab
- Drug safety evaluation of exemestane
- Unusual progression of renal cell carcinoma with carcinomatosis peritoneii and Krukenberg tumour and alopecia with sunitinib therapy in young female
- Association of breast cancer in men with exposure to 5-α reductase inhibitors: A RADAR report.
- Nearly complete hair re-pigmentation in an older patient treated with hydroxyurea for essential thrombocytosis
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- Real-world pharmacovigilance insights into drug-induced risk of alopecia
- Drug-Induced Hair Loss and Hair Growth
- Drug-Induced Skin, Nail and Hair Disorders
- Drug-induced acne
- 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D3 analogue in humans